Cryptosporidium Infection in Undernourished Children with HIV/AIDS in Jos, Nigeria

Background: AIDS and Protein energy malnutrition (PEM) severely impair the immune system Cryptosporidium has over the last two decades emerged as a life threatening disease. The study attempts to determine the prevalence of Cryptosporidium infection in malnourished children with HIV/AIDS. Method: Blood and stool samples of 52 HIV-seropositive children and another 52 HIV-sero-negative children aged 0-5 years were collected and screened for HIV and Cryptosporidium oocysts respectively. The sera were screened by double ELISA and the stool by the modified Ziehl-Neelsen method. Results: Out of the 52 HIV-seropositive undernourished, under-five children, none (0%) excreted Cryptosporidium oocyst in their stools while 2 (3.8%) of the control group excreted the oocyst. Conclusion: Cryptosporidium infection seems to be uncommon among undernourished under five children with HIV/AIDS in Jos

Hepatitis C Virus Antibodies Among Blood Donors in Jos, Nigeria

Background: Hepatitis C virus (HCV) is one of the hepatitis agents known to be transmitted through blood and blood products. Hepatitis C virus has been implicated as a major cause of chronic liver disease and hepatocellular carcinoma worldwide. This study was, therefore, undertaken with the objective of determining the sero-prevalence of HCV antibodies among blood donors in the central city of Jos, Nigeria. Method: A total of two hundred blood donors were recruited from three hospitals within Jos metropolis. Sera from all subjects were tested for Hepatitis C virus antibodies using a second generation enzyme linked immunosorbent assay (ELISA). Results: Ninety five percent (95%)of the blood donors were males and most of them were aged between 21 and 50years. Twelve (6.0%)of the blood donors were anti-HCV seropositive and all of them males. Conclusion: There is an urgent need to introduce routine screening of blood donors for Hepatitis C virus markers in centers where this is not currently been practiced. This will reduce the risk of transfusion-associated hepatitis C infection and its complications in Nigeria

Understanding the Phylogenetics and Evolution of Genus Schistosoma- Africa and Asia Stand Point.

The evolutionary spread of schistosomes infection was reportedly prominent more in Africa and Asia continents. This study therefore examined the evolutionary trend of this parasite while limiting the investigation to Schistosoma species peculiar to this region of the world. The evolutionary history of this species group was inferred using DNA sequences from NCBI Genbank database and Maximum likelihood, Ancestral inference; Neighbor-Joining method analysis was employed in this study. All members of this species complex were AT rich, with S. mekongi and S. malayensis having the highest AT nucleotide composition. The smallest evolutionary divergence was also observed in S. curassoni and S. bovis. The finding of this study slightly contradict previous report on ancestral prediction of Schistosomes

HEPATITIS C VIRUS ANTIBODIES AMONG BLOOD DONORS IN JOS, NIGERIA

Abstract Background: Hepatitis C virus (HCV) is one of the hepatitis agents known to be transmitted through blood and blood products. Hepatitis C virus has been implicated as a major cause of chronic liver disease and hepatocellular carcinoma worldwide. This study was, therefore, undertaken with the objective of determining the sero-prevalence of HCV antibodies among blood donors in the central city of Jos, Nigeria. Method: A total of two hundred blood donors were recruited from three hospitals within Jos metropolis. Sera from all subjects were tested for Hepatitis C virus antibodies using a second generation enzyme linked immunosorbent assay (ELISA). Results: Ninety five percent (95%)of the blood donors were males and most of them were aged between 21 and 50years. Twelve (6.0%)of the blood donors were anti-HCV seropositive and all of them males. Conclusion: There is an urgent need to introduce routine screening of blood donors for Hepatitis C virus markers in centers where this is not currently been practiced. This will reduce the risk of transfusion-associated hepatitis C infection and its complications in Nigeria